Status:

COMPLETED

Clarithromycin as Immunomodulator for the Management of Sepsis

Lead Sponsor:

University of Athens

Conditions:

Sepsis

Severe Sepsis

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

The herein protocol is based on the results of one former clinical trial conducted by our study group showing the considerable efficacy of intravenously administered clarithromycin as an adjuvant to a...

Detailed Description

The idea for the application of intravenous clarithromycin as immunomodulatory therapy for the management of sepsis has been evolved on in vitro results showing that concentrations close to 10μg/ml ma...

Eligibility Criteria

Inclusion

  • One or more of the following infections: a) primary or secondary bacteremia by Gram-negative bacteria, b) acute pyelonephritis, or c) intrabdominal infection. Only one episode of infection per patient will be enrolled. Both patients with community-acquired and nosocomial infections are eligible for the study.
  • The presence of at least two of the following criteria of sepsis according to ACCP/SCCM (8) a) body temperature \>38 degreesC or \<36 degreesC; b) pulse rate \>90/min; c) breath rate \>20/min or Pco2\<32mmHg; and/or d) leukocytosis (white blood cell count \>12,000/μl) or leukopenia (white blood cell count \<4,000/μl) or \>10% band forms

Exclusion

  • Presence of HIV infection
  • Intake of corticosteroids at a dose more than or equal to 1mg/kg of equivalent prednisone for more than one month
  • Neutropenia as \<500 neutrophils/μl
  • Selection by the attending physician of a macrolide as empiric antimicrobial therapy for the infection making the patient eligible for the study

Key Trial Info

Start Date :

July 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2011

Estimated Enrollment :

600 Patients enrolled

Trial Details

Trial ID

NCT01223690

Start Date

July 1 2007

End Date

April 1 2011

Last Update

August 4 2011

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

3rd Department of Critical Care Medicine, National and Kapodistrian University of Athens

Athens, Greece, 11528

2

2nd Department of Critical Care Medicine, National and Kapodistrian University of Athens

Athens, Greece, 12462

3

4th Department of Internal Medicine, National and Kapodistrian University of Athens

Athens, Greece, 12462

4

2nd Department of Medicine, Sismanogleion General Hospital

Athens, Greece, 15126

Clarithromycin as Immunomodulator for the Management of Sepsis | DecenTrialz